KELLIE FURLOW: Open Payments
NPI 1255976106 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 21 payments from 12 companies in 2025. Trend: 2023 $821 · 2024 $1,323 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $60 |
| Corium, LLC | 2 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Neos Therapeutics, LP | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $24 |
| Almatica Pharma LLC | 1 | $23 |
Products named: TRINTELLIX, REXULTI, Azstarys, INGREZZA, ARISTADA, Adzenys XR-ODT, CAPLYTA, Auvelity.
Industry payments across FL — which companies pay providers there.
